{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:40:01Z","timestamp":1750542001690,"version":"3.41.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 68-year-old man with right cheek melanoma after resection underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT, which was unremarkable except for multiple FDG-avid subcentimeter but rounded lymph nodes in the left axilla. The patient had undergone a COVID-19 vaccination in the left arm 3 weeks prior. As under vaccinations have been documented to cause reactive FDG-avid lymph nodes, the nodes in our patient were considered benign, reactive to the COVID-19 vaccination. Although FDG-avid benign, reactive nodes have been an uncommon finding in the past, the upcoming surge in COVID-19 vaccinations makes this an important finding for the interpreting physician to consider and recognize.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003633","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:03:35Z","timestamp":1617077015000},"page":"433-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["18F-FDG\u2013Avid Lymph Nodes After COVID-19 Vaccination on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"46","author":[{"given":"Gary A.","family":"Ulaner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China","volume":"382","year":"2020","journal-title":"N Engl J Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","year":"2020","journal-title":"JAMA"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","volume":"27","year":"2021","journal-title":"Nat Med"},{"journal-title":"N Engl J Med","article-title":"Last-mile logistics of covid vaccination\u2014the role of health care organizations","year":"2021","key":"bib4-20250621"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/RLU.0000000000003141","article-title":"Laboratory-proven asymptomatic SARS-CoV-2 (COVID-19) infection on 18F-FDG PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nuc Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1148\/radiol.2020201237","article-title":"Chest CT features of COVID-19 in Rome, Italy","volume":"296","year":"2020","journal-title":"Radiology"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00259-020-04735-9","article-title":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/RLU.0b013e3182177322","article-title":"Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/RLU.0000000000001603","article-title":"Lymph node activation by PET\/CT following vaccination with licensed vaccines for human papillomaviruses","volume":"42","year":"2017","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:39Z","timestamp":1750539819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003633","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}